US EditionPublished • loading... • Updated
Novo Halts Work on Cell Therapy Cure for Diabetes to Cut Costs
Summary by Bloomberg
1 Articles
1 Articles
Novo Halts Work on Cell Therapy Cure for Diabetes to Cut Costs
Novo Nordisk A/S cut its cell therapy division, which has been trying to find a cure for type 1 diabetes, as the Ozempic maker continues to slash headcount to focus on lucrative areas of obesity and diabetes treatment.
·United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
